info@seagull-health.com
SeagullHealth
语言:
search

Who can use MYFEMBREE(Relugolix)?

MYFEMBREE, containing relugolix, is for premenopausal women. It can manage heavy menstrual bleeding from uterine fibroids and moderate to severe pain from endometriosis. 

Who can use MYFEMBREE(Relugolix)?

However, it’s not suitable for those at high risk of thrombotic disorders, pregnant women, those with osteoporosis, hormone - sensitive malignancies, hepatic impairment, undiagnosed abnormal uterine bleeding, or hypersensitivity to its components.MYFEMBREE, containing relugolix, is for premenopausal women. It can manage heavy menstrual bleeding from uterine fibroids and moderate to severe pain from endometriosis. 

However, it’s not suitable for those at high risk of thrombotic disorders, pregnant women, those with osteoporosis, hormone - sensitive malignancies, hepatic impairment, undiagnosed abnormal uterine bleeding, or hypersensitivity to its components.

Relugolix(MYFEMBREE)
Relugolix(MYFEMBREE)
Relugolix is indicated for patients with heavy menstrual bleeding associated...
WeChat Scan
Free Inquiry
Related articles
What Are the Indications of Relugolix?
Relugolix is an oral medication, often used in combination with estradiol and norethindrone acetate to form the fixed-dose combination product relugolix. It is mainly indicated for the treatment of he...
What are the Indications of Relugolix (Orgovyx)?
Relugolix (Orgovyx) is a novel gonadotropin-releasing hormone (GnRH) receptor antagonist that was approved in the United States in 2020 for the treatment of prostate cancer.What are the Indications of...
Relugolix tablet instructions
Relugolix tablets are a drug used to treat heavy menstrual bleeding and moderate to severe pain caused by uterine fibroids or endometriosis in premenopausal women. Relugolix has not yet been...
Indications of Relugolix
Relugolix, also known as MYFEMBREE, is an oral gonadotropin-releasing hormone (GnRH) receptor antagonist. It blocks the binding of endogenous GnRH to its receptor, reduces the release of luteinizing h...
共 4 条
  • 1
前往
New Drugs
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Faricimab-svoa(Vabysmo)
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • mailbox:info@lucius.la
Welcome to consult
ucius Pharmaceuticals (Lao) Co.,Ltd All rights reserved